<i>In vivo</i> efficacy of cefiderocol against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant <i>Pseudomonas aeruginosa</i> carrying the AmpC E219K substitution. [PDF]
Rodríguez-Coello A +14 more
europepmc +1 more source
Hope Against Resistance: In Vitro Activity of the Ceftazidime-Avibactam and Aztreonam Combination Against Colistin-Resistant Klebsiella pneumoniae. [PDF]
Mutha M, Subramani P, A R.
europepmc +1 more source
Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infections. [PDF]
Karaba SM +9 more
europepmc +1 more source
Efficacy and safety of ceftazidime-avibactam in carbapenem-resistant gram-negative bacilli sepsis according to infection site. [PDF]
Ru S, Ji F, Yang G, Xv H.
europepmc +1 more source
Ceftazidime-avibactam as a polymyxin-sparing option for multidrug-resistant Gram-negative infections in children: a real-world comparative cohort study. [PDF]
Aslan Tuncay S +12 more
europepmc +1 more source
Combating Carbapenem-Resistant <i>Enterobacterales</i>: Comparative <i>In Vitro</i> Efficacy of Aztreonam-Avibactam and Ceftazidime-Avibactam and Distribution of Carbapenemase Genes. [PDF]
Yaşar Duman M +4 more
europepmc +1 more source
Physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials in simulated Y-site administration. [PDF]
Chen F +5 more
europepmc +1 more source
Recalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam. [PDF]
Feng C.
europepmc +1 more source
Fitness cost of ceftazidime-avibactam resistance acquisition in carbapenem-resistant hypervirulent Klebsiella pneumoniae. [PDF]
Huang M +6 more
europepmc +1 more source

